William H. Briner Distinguished Achievement Award In Nuclear Pharmacy Practice
2025 William H. Briner Distinguished Achievement Award In Nuclear Pharmacy Practice Recipient
Mark Soffing BCNP, PharmD, MBA, MS
Mark Soffing’s first “exposure” to nuclear pharmacy was an externship at Staten Island
Public Health Hospital, supervised by Neil Abel, an Officer originally trained by William Briner. Over
the ensuing 42 years, he has had the good fortune to marry Joanne, an extremely-patient wife, and have
two married children and one grandson.
Dr. Soffing began work at Syncor on Long Island. He was later recruited to establish
Nuclear Pharmacy satellites, along with local and remote University externships, at New York Hospital
and Memorial Sloan-Kettering. He then went on to join IBA Molecular as VP Regulatory and Corporate
Radiation Safety Officer (RSO), later becoming VP Operations. For the last 15 years, Dr. Soffing serves
as Associate Director and Cyclotron RSO of the PET Center at Columbia University.
After receiving his BS in Pharmacy from St. John’s University, Dr. Soffing completed
Radiopharmacy-AU Certificate at USC. He went on to earn an MS in Radiation Science from Rutgers
University, an MBA from NYU Stern School of Business and completed a Doctor of Pharmacy Degree at the
University of Florida.
Dr. Soffing has been an active APhA member, serving as Member-At-Large for the Nuclear
Pharmacy Practice Section from 2005-2007, and spearheaded the creation of the first three live BCNP CE
Sessions, University-accredited, for the APhA Annual Meeting. When elected Nuclear Pharmacy Special
Interest Group Coordinator-elect and Coordinator from 2013-2015, he saw to it that that the
Radiopharmaceutical Supplier Qualification Tool was completed and ready for publication by APhA by the
end of his term. He also serves on several committees for the Society of Nuclear Medicine, maintains
plenary membership in the Health Physics Society, and remains a member of ASHP.
Dr. Soffing was selected as a Member of the New York State Board of Pharmacy in 2021,
serving on its USP and MPJE Sub-Committees.
About
This award, named in memory of Captain William H. Briner, a pioneer in the development of the nuclear
pharmacy practice specialty, recognizes the achievements of an individual who has made a significant
contribution or sustained contributions to the provision of pharmaceutical care within nuclear pharmacy
practice. Premier support for this award is provided by the National Association of Nuclear Pharmacies.
Criteria
The nominee for the APhA William H. Briner Distinguished Achievement Award in Nuclear Pharmacy Practice must
be a pharmacist who is a member of APhA and who has made significant or sustained contributions to the
practice area(s).
Nomination process
The nominator is responsible for submitting a complete award nomination.
The nomination is to include the following items:
A letter of nomination describing the most important achievements of the nominee and explaining why the
nominee meets the criteria for the award
One letter of recommendation from someone other than the nominator is required, up to two letters are
accepted
A current curriculum vitae or detailed resume
Selection process
The selection is made by the APhA Radiopharmaceutical Community based upon careful review of the complete
nominations and criteria as listed above. Particular attention will be given to the individual’s impact on
the profession.
Nature of award
The award is presented at the APhA Annual Meeting & Exposition and consists of a crystal recognition
piece. The recipient will also receive a complimentary APhA Annual Meeting registration and reimbursement
for meeting-related travel expenses, according to current travel policies and up to the maximum amount
budgeted by APhA.
Past Recipients
2018 Duann V. Thistlethwaite
2014 Jeffrey P. Norenberg
2011 Kristina M. Wittstrom
Return to Main Awards Page